Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Cantor Fitzgerald
Argus Health
Chubb
Healthtrust
McKesson
Fuji
Daiichi Sankyo
Covington

Generated: January 23, 2018

DrugPatentWatch Database Preview

Pantoprazole sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pantoprazole sodium and what is the scope of pantoprazole sodium freedom to operate?

Pantoprazole sodium
is the generic ingredient in three branded drugs marketed by Wyeth Pharms Inc, Akorn Inc, Aurobindo Pharma Ltd, Sandoz Inc, Exela Pharma Scs Llc, Actavis Totowa, Amneal Pharms, Apotex Inc, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Jubilant Generics, Kremers Urban Pharms, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Perrigo R And D, Sun Pharm Inds Ltd, Teva, Torrent Pharms, and Wockhardt, and is included in twenty-four NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Pantoprazole sodium has one hundred and five patent family members in forty-seven countries.

There are forty-eight drug master file entries for pantoprazole sodium. Sixty-two suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for pantoprazole sodium
Pharmacology for pantoprazole sodium
Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors
Tentative approvals for PANTOPRAZOLE SODIUM
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe40MGINJECTABLE; INJECTION
➤ Subscribe➤ SubscribeEQ 40MG BASE/VIALINJECTABLE; IV (INFUSION)

US Patents and Regulatory Information for pantoprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 202052-001 Dec 2, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-002 Jun 12, 2001 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wockhardt PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 091231-002 Jan 19, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd V PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 202882-001 Sep 10, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 022020-001 Nov 14, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Orchid Hlthcare PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 202052-002 Dec 2, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kremers Urban Pharms PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 078281-002 Jan 20, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 022020-001 Nov 14, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aurobindo Pharma Ltd PANTOPRAZOLE SODIUM pantoprazole sodium INJECTABLE;IV (INFUSION) 205675-001 Mar 30, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 091231-001 Jan 19, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for pantoprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-001 Feb 2, 2000 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 022020-001 Nov 14, 2007 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-002 Jun 12, 2001 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-001 Feb 2, 2000 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-002 Jun 12, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for pantoprazole sodium

Supplementary Protection Certificates for pantoprazole sodium

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0032 Belgium ➤ Subscribe PRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506
C/GB96/056 United Kingdom ➤ Subscribe PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
US Army
Medtronic
McKesson
AstraZeneca
Teva
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot